Bruker Daltonics and Queensland Institute of Medical Research Expand Collaboration with Installation of maXis™ UHR-TOF
News Jan 06, 2009
Bruker Daltonics and the Queensland Institute of Medical Research (QIMR) have announced the installation of the first maXis™ Ultra-High Resolution Time-Of-Flight (UHR-TOF) mass spectrometer in Australasia, thereby further strengthening the collaboration between Bruker and QIMR.
According to Bruker Daltonics, maXis is the only instrument available that uniquely combines the previously incompatible trends in modern mass spectrometry of ultra-high resolution and fast chromatographic separations. High resolution and sensitivity are maintained even when coupled to liquid chromatography systems.
"Bruker is delighted to further strengthen the collaborative relationship we have developed with Professor Gorman and QIMR. The installation of maXis, the first in Australasia, offers a major opportunity for us to co-develop the advanced methodologies required for the wide range of applications undertaken at QIMR's Protein Discovery Centre (PDC)," stated Clive Seymour, Executive Vice President of Bruker Daltonics.
"The installation of maXis will allow us to collaborate more extensively with Bruker, particularly in the development of ETD methodologies for the study of post-translational modifications on this exciting new platform, and represents a quantum leap in MS capability at QIMR," commented Professor Jeff Gorman, Director of the PDC.
Chinese researchers have developed interfacially polymerized porous polymer particles for low- abundance glycopeptide separation. These polymer particles - with hydrophilic-hydrophobic heterostructured nanopores - can separate low-abundance glycopeptides from complex biological samples with high-abundance background molecules efficiently.